Agilent has FDA approval for a test to identify ovarian cancer patients who may be eligible for immunotherapy. Agilent’s PD-L1 IHC 22C3 pharmDx is the only...
Breakthroughs in cancer care don’t only come from large institutions or fully funded labs. They also come from determined individuals, small teams, early-stage founders, clinicians with...
An AI tool cut interval breast cancers by 12 per cent in a Swedish screening trial of more than 105,000 women. The study also found 27...
London’s shifting population is holding down breast screening uptake, experts have said, with the capital at 62.8 per cent in 2024, below the NHS’s acceptable 70...
Testing period blood for signs of cervical cancer could offer an accurate, convenient screening option for women who avoid clinic appointments, researchers say. The current NHS...
A surgical procedure developed in Canada reduces the risk of the most common and deadly form of ovarian cancer by nearly 80 per cent. The strategy,...
A recent study published in the BJS has found that switching to the Magseed marker could significantly reduce costs from increased scheduling flexibility and reduced operating...
AI mammography finds more cancers at screening and cuts diagnoses between screens by 12 per cent, a major trial has found. The study involving over 100,000...
Patients in deprived and underserved areas of England will receive earlier cancer diagnosis through a new £200 million scheme to tackle postcode lotteries in cancer care....
A new NHS gene database of 120 cancer-linked genes will help patients in England and their families assess their cancer risk, the health service says. People...
